Skip to main content
Top
Published in: International Journal of Hematology 5/2021

01-05-2021 | Macrohematuria | Original Article

Prevalence of and risk factors for urolithiasis in Croatian patients with hemophilia

Authors: Marijo Vodanović, Marko Lucijanić, Silva Zupančić Šalek, Ivan Pećin

Published in: International Journal of Hematology | Issue 5/2021

Login to get access

Abstract

Urolithiasis may be more prevalent in patients with hemophilia (PWH) than in age-matched non-hemophilic males. We conducted a cross-sectional evaluation of 92 adult PWH at University Hospital Center Zagreb. The primary objective was to investigate the frequency of urolithiasis in adult PWH, and the secondary objective was to determine associated risk factors. Urolithiasis was diagnosed by ultrasound and other patient- and hemophilia-related parameters were recorded. The prevalence of urolithiasis was significantly higher among PWH than the reported prevalence in the general Croatian population (10.9% vs 5.9%; P = 0.042). Similarly, the incidence of urolithiasis during the course of the disease was significantly higher than the estimated cumulative lifetime incidence of urolithiasis in the Croatian population (25% vs 12%; P = 0.001). Multivariate analysis showed that arterial hypertension, the presence of inhibitors, hypercalciuria and hyperbilirubinemia were independent predictors of current urolithiasis (P < 0.05), and that hematuria (P = 0.051) and prior urinary infections (P = 0.059) were also relevant factors.
Urolithiasis is a significant burden in adult PWH. Identifying associated risk factors might help in establishing strategies for earlier recognition and more successful prevention and treatment of urolithiasis.
Literature
1.
go back to reference Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1-47.CrossRef Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1-47.CrossRef
2.
go back to reference Shapiro S, Makris M. Haemophilia and ageing. Br J Haematol. 2019;184(5):712–20.CrossRef Shapiro S, Makris M. Haemophilia and ageing. Br J Haematol. 2019;184(5):712–20.CrossRef
3.
go back to reference Canaro M, Goranova-Marinova V, Berntorp E. The ageing patient with haemophilia. Eur J Haematol. 2015;94(Suppl 77):17–22.CrossRef Canaro M, Goranova-Marinova V, Berntorp E. The ageing patient with haemophilia. Eur J Haematol. 2015;94(Suppl 77):17–22.CrossRef
4.
go back to reference Kulkarni R, Soucie JM, Evatt B. Hemophilia surveillance system project investigators. Renal disease among males with haemophilia. Haemophilia. 2003;9(6):703–10.CrossRef Kulkarni R, Soucie JM, Evatt B. Hemophilia surveillance system project investigators. Renal disease among males with haemophilia. Haemophilia. 2003;9(6):703–10.CrossRef
5.
go back to reference Esposito P, Rampino T, Gregorini M, Fasoli G, Gamba G, Dal Canton A. Renal diseases in haemophilic patients: pathogenesis and clinical management. Eur J Haematol. 2013;91(4):287–94.PubMed Esposito P, Rampino T, Gregorini M, Fasoli G, Gamba G, Dal Canton A. Renal diseases in haemophilic patients: pathogenesis and clinical management. Eur J Haematol. 2013;91(4):287–94.PubMed
6.
go back to reference Ghosh K, Jijina F, Mohanty D. Haematuria and urolithiasis in patients with haemophilia. Eur J Haematol. 2003;70(6):410–2.CrossRef Ghosh K, Jijina F, Mohanty D. Haematuria and urolithiasis in patients with haemophilia. Eur J Haematol. 2003;70(6):410–2.CrossRef
7.
go back to reference Ranta S, Valta H, Viljakainen H, Mäkitie O, Mäkipernaa A. Hypercalciuria and kidney function in children with haemophilia. Haemophilia. 2013;19(2):200–5.CrossRef Ranta S, Valta H, Viljakainen H, Mäkitie O, Mäkipernaa A. Hypercalciuria and kidney function in children with haemophilia. Haemophilia. 2013;19(2):200–5.CrossRef
8.
go back to reference Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of cardiology and the European society of hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.CrossRef Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of cardiology and the European society of hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.CrossRef
9.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.CrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.CrossRef
10.
go back to reference Oguić R, Dimec D, Markić D. Urolitijaza-prevencija, dijagnostika i liječenje. Medicina. 2004;42(40):95–102. Oguić R, Dimec D, Markić D. Urolitijaza-prevencija, dijagnostika i liječenje. Medicina. 2004;42(40):95–102.
11.
go back to reference Tucak A, Kalem T, Cvijetić S, Galić J, Prlić D, Zorić I, et al. The incidence and risk factors of urolithiasis in active working population of the Osijek community: an epidemiological study. Period Biol. 2000;102(4):431–5. Tucak A, Kalem T, Cvijetić S, Galić J, Prlić D, Zorić I, et al. The incidence and risk factors of urolithiasis in active working population of the Osijek community: an epidemiological study. Period Biol. 2000;102(4):431–5.
12.
go back to reference Šerić V, Babić-Ivančić V, Marković M, Šerić V, Cvijetić Avdagić S, Füredi-Milhofer H. Važnost suradnje i interdisciplinarnoga pristupa u rješavanju problema urolitijaze: jučer, danas, sutra. Med Vjesn. 2010;42(3–4):19–31. Šerić V, Babić-Ivančić V, Marković M, Šerić V, Cvijetić Avdagić S, Füredi-Milhofer H. Važnost suradnje i interdisciplinarnoga pristupa u rješavanju problema urolitijaze: jučer, danas, sutra. Med Vjesn. 2010;42(3–4):19–31.
13.
go back to reference Ranta S, Viljakainen H, Mäkipernaa A, Mäkitie O. Hypercalciuria in children with haemophilia suggests primary skeletal pathology. Br J Haematol. 2011;153(3):364–71.CrossRef Ranta S, Viljakainen H, Mäkipernaa A, Mäkitie O. Hypercalciuria in children with haemophilia suggests primary skeletal pathology. Br J Haematol. 2011;153(3):364–71.CrossRef
14.
go back to reference Holme PA, Combescure C, Tait RC, Berntorp E, Rauchensteiner S, de Moerloose P; ADVANCE Working Group. Hypertension, haematuria and renal functioning in haemophilia—a cross-sectional study in Europe. Haemophilia. 2016;22(2):248–255. Holme PA, Combescure C, Tait RC, Berntorp E, Rauchensteiner S, de Moerloose P; ADVANCE Working Group. Hypertension, haematuria and renal functioning in haemophilia—a cross-sectional study in Europe. Haemophilia. 2016;22(2):248–255.
15.
go back to reference Cappuccio FP, Strazzullo P, Mancini M. Kidney stones and hypertension: population based study of an independent clinical association. BMJ (Clinical Research ed). 1990;300(6734):1234–6.CrossRef Cappuccio FP, Strazzullo P, Mancini M. Kidney stones and hypertension: population based study of an independent clinical association. BMJ (Clinical Research ed). 1990;300(6734):1234–6.CrossRef
16.
go back to reference Qvigstad C, Tait RC, de Moerloose P, Holme PA; ADVANCE Working Group. Hematuria in aging men with hemophilia: Association with factor prophylaxis. Res Pract Thromb Haemost. 2020;4(2):309–317. Qvigstad C, Tait RC, de Moerloose P, Holme PA; ADVANCE Working Group. Hematuria in aging men with hemophilia: Association with factor prophylaxis. Res Pract Thromb Haemost. 2020;4(2):309–317.
17.
go back to reference Grossfeld GD, Carroll PR. Evaluation of asymptomatic microscopic hematuria. Urol Clin North Am. 1998;25(4):661–76.CrossRef Grossfeld GD, Carroll PR. Evaluation of asymptomatic microscopic hematuria. Urol Clin North Am. 1998;25(4):661–76.CrossRef
18.
go back to reference Prentice CR, Lindsay RM, Barr RD, Forbes CD, Kennedy AC, McNicol GP, et al. Renal complications in haemophilia and Christmas disease. Q J Med. 1971;40(157):47–61.PubMed Prentice CR, Lindsay RM, Barr RD, Forbes CD, Kennedy AC, McNicol GP, et al. Renal complications in haemophilia and Christmas disease. Q J Med. 1971;40(157):47–61.PubMed
Metadata
Title
Prevalence of and risk factors for urolithiasis in Croatian patients with hemophilia
Authors
Marijo Vodanović
Marko Lucijanić
Silva Zupančić Šalek
Ivan Pećin
Publication date
01-05-2021
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 5/2021
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-03064-9

Other articles of this Issue 5/2021

International Journal of Hematology 5/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine